GRAPHITE BIO INC's ticker is GRPH and the CUSIP is 38870X104. A total of 63 filers reported holding GRAPHITE BIO INC in Q3 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $420,886 | -3.6% | 169,712 | +1.0% | 0.00% | 0.0% |
| Q2 2023 | $436,810 | +24.1% | 168,004 | +16.9% | 0.00% | 0.0% |
| Q1 2023 | $352,055 | -49.1% | 143,696 | -31.0% | 0.00% | -50.0% |
| Q4 2022 | $691,778 | -16.1% | 208,367 | -20.0% | 0.00% | -33.3% |
| Q3 2022 | $825,000 | -31.4% | 260,328 | -40.5% | 0.00% | -25.0% |
| Q2 2022 | $1,202,000 | – | 437,265 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 8,459,314 | $20,979,099 | 6.42% |
| OUP Management Co., LLC | 406,308 | $1,007,644 | 2.27% |
| Prosight Management, LP | 1,337,826 | $3,317,808 | 1.05% |
| EcoR1 Capital, LLC | 8,538,446 | $21,175,346 | 0.71% |
| TANG CAPITAL MANAGEMENT LLC | 2,016,626 | $5,001,232 | 0.71% |
| Privium Fund Management (UK) Ltd | 191,244 | $453,248 | 0.36% |
| Newtyn Management, LLC | 542,637 | $1,345,740 | 0.33% |
| Aldebaran Capital, LLC | 130,000 | $322,400 | 0.33% |
| Acuitas Investments, LLC | 195,762 | $485,490 | 0.28% |
| CHI Advisors LLC | 230,938 | $572,726 | 0.23% |